Dosimertinib-d 3

Overview

Dosimertinib-d 3 -d 3 is a potent and orally active EGFR inhibitor . Dosimertinib-d 3 -d 3 decreases the expression of p-EGFR and p-ERK protein levels. Dosimertinib-d 3 -d 3 shows antiproliferative and anti-tumor activity. Dosimertinib-d 3 -d 3 has the potential for the research of non-small-cell lung cancer (NSCLC).

Application

Products | Products > Signaling Pathways > Others | Products > Signaling Pathways > JAK/STAT Signaling | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Isotope-Labeled Compounds | Products > Signaling Pathways > EGFR

Product Information

• Catalog No.: HY-142283
• CAS No.: 2403760-70-1
• Molecular Formula: C28H28D5N7O2
• Molecular Weight: 504.64
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.
• Availability: In-stock

Source

Original product source